Cargando…

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine

Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb), kills 5,000 people per day globally. Rapid development and spread of various multi drug-resistant strains of Mtb emphasize that an effective vaccine is still the most cost-effectives and efficient way of controlling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Nancy, Garg, Saurabh, Vedi, Satish, Kunimoto, Dennis Y., Kumar, Rakesh, Agrawal, Babita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198790/ https://www.ncbi.nlm.nih.gov/pubmed/30386336 http://dx.doi.org/10.3389/fimmu.2018.02371

Ejemplares similares

Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic
por: Gupta, Nancy, et al.
Publicado: (2023)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
por: Agrawal, Babita, et al.
Publicado: (2019)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines
por: Singh, Shakti, et al.
Publicado: (2016)

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
por: Dijkman, Karin, et al.
Publicado: (2023)

Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2022)

Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory
por: Lv, Wei, et al.
Publicado: (2022)

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
por: Agrawal, Babita, et al.
Publicado: (2017)

BCG vaccination policy, natural boosting and pediatric brain and CNS tumor incidences
por: Singh, Samer, et al.
Publicado: (2023)

The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
por: Billeskov, Rolf, et al.
Publicado: (2012)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
por: Pooransingh, Shalini, et al.
Publicado: (2020)

TB infection and BCG vaccination: are we protected from COVID-19?
por: Madan, M., et al.
Publicado: (2020)

Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
por: Tkachuk, A. P., et al.
Publicado: (2017)

Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques
por: Vierboom, Michel P. M., et al.
Publicado: (2020)

‘Fight TB with BCG’: Mass Vaccination Campaigns in the British Caribbean, 1951–6
por: Altink, Henrice
Publicado: (2014)

761. Age-Related Incidence of TB Infection Supporting Efficacy of BCG Vaccination
por: Sweeney, Eileen, et al.
Publicado: (2018)

Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2014)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
por: White, Andrew D., et al.
Publicado: (2021)

Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
por: Thysen, Sanne M, et al.
Publicado: (2020)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

109 Problems and prospects of development of the subunit TB vaccine
por: Tkachuk, A.B., et al.
Publicado: (2014)

BCG Vaccination
Publicado: (1989)

BCG Vaccination
por: Miller, Russell
Publicado: (1953)

Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice
por: Hu, Zhidong, et al.
Publicado: (2017)

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
por: Gonçalves, Eduardo DC, et al.
Publicado: (2007)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis
por: Nandakumar, Subhadra, et al.
Publicado: (2016)

Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population
por: Yang, Chin-Hui, et al.
Publicado: (2013)

BCG vaccine in Korea
por: Joung, Sun Myung, et al.
Publicado: (2013)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
por: Khan, Nadia H., et al.
Publicado: (2022)

Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects
por: Fritschi, Nora, et al.
Publicado: (2020)

Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia
por: Mukherjee, Sanjay, et al.
Publicado: (2017)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

BCG Vaccine Protection against TB Infection among Children Older than 5 Years in Close Contact with an Infectious Adult TB Case
por: Syggelou, Angeliki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_idnock2cmaij643dbl2k339rsq